At NeonMind Biosciences, we believe in “mind over matter”. We plan to help people change their lives by changing their minds, through treatment with psychedelics.
Obesity accounts for
of the global burden of disease.
NeonMind is exploring psilocybin (a complex organic compound found in psychedelic mushrooms) as an innovative treatment approach to weight loss through a preclinical trial. We know that psilocybin is known to activate serotonin receptors, and that serotonin can curb cravings, shut off appetite, and reduce eating. We’ve hired the University of British Columbia to conduct our Preclinical Trial, exploring the potential therapeutic use of psilocybin to improve eating habits and cause weight loss.
The landscape is rapidly changing when it comes to the use of psychedelics for medical treatments. There is a major shift on the horizon and we believe in the potential for psychedelics to revolutionize the way we treat issues around mental health and obesity.
Our Formula Catalog
We hold the global rights to a robust catalog of more than 145 product formulations for infusion with functional mushrooms to promote health and wellness.